Boxer Capital Management, LLC

Boxer Capital Management, LLC reported 47 holdings worth US$1.15B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Boxer Capital Management, LLC reported 47 holdings worth US$1.15B as of Sep 30, 2026. Largest: Tango Therapeutics, Inc., Kodiak Sciences Inc and Revolution Medicines, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
47
Value as reported
US$1.15B

The filing in full

CompanySharesValue as reported% of portfolio
Tango Therapeutics, Inc.10.5MUS$263M22.8%
Kodiak Sciences Inc1.48MUS$140M12.2%
Revolution Medicines, Inc.500KUS$103M8.9%
Kymera Therapeutics, Inc.525KUS$58.6M5.1%
Replimune Group, Inc.4.28MUS$56.6M4.9%
Abivax SA475KUS$47M4.1%
Surrozen, Inc.1.36MUS$43.8M3.8%
Corcept Therapeutics Incorporated336KUS$38.7M3.4%
Precigen, Inc.4.32MUS$37M3.2%
Definium Therapeutics, Inc.684KUS$26M2.3%
Amylyx Pharmaceuticals, Inc.893KUS$26M2.3%
Spyre Therapeutics, Inc.283KUS$25.2M2.2%
Protagonist Therapeutics, Inc.170KUS$24M2.1%
Celcuity Inc.286KUS$22.8M2.0%
Opus Genetics, Inc.4.53MUS$21.9M1.9%
Q32 Bio Inc.2.58MUS$21.3M1.9%
Achieve Life Sciences, Inc.2.15MUS$17.4M1.5%
C4 Therapeutics, Inc.4.15MUS$13.8M1.2%
First Tracks Biotherapeutics, Inc.240KUS$8.51M0.74%
Shattuck Labs, Inc.1.18MUS$8.02M0.70%
SAB Biotherapeutics, Inc.2.5MUS$7.92M0.69%
Cullinan Therapeutics, Inc.450KUS$6.91M0.60%
Contineum Therapeutics, Inc.494KUS$6.63M0.58%
Cytokinetics, Incorporated100KUS$6.59M0.57%
Palisade Bio, Inc.4.8MUS$6.48M0.56%
Capricor Therapeutics, Inc.643KUS$6.09M0.53%
Electra Therapeutics, Inc.450KUS$5.06M0.44%
AN2 Therapeutics, Inc.944KUS$5.02M0.44%
Maze Therapeutics, Inc.175KUS$4.77M0.41%
Edesa Biotech, Inc.937KUS$3.95M0.34%
Relay Therapeutics, Inc.200KUS$3.61M0.31%
Kazia Therapeutics Ltd372KUS$3.56M0.31%
Attovia Therapeutics, Inc.200KUS$3.43M0.30%
PMV Pharmaceuticals, Inc.2.05MUS$3.42M0.30%
Zentalis Pharmaceuticals, Inc.1.01MUS$2.81M0.24%
Sarepta Therapeutics, Inc.150KUS$2.73M0.24%
Allogene Therapeutics, Inc.1.5MUS$2.4M0.21%
Nurix Therapeutics, Inc.100KUS$2.37M0.21%
Sionna Therapeutics, Inc.392KUS$2.06M0.18%
Clene Inc.478KUS$1.95M0.17%
Aclaris Therapeutics, Inc.300KUS$1.58M0.14%
Milestone Pharmaceuticals Inc.667KUS$577K0.05%
Neumora Therapeutics, Inc.954KUS$569K0.05%
Karyopharm Therapeutics Inc.128KUS$156K0.01%
Regenxbio Inc.0US$00.00%
Relmada Therapeutics, Inc.0US$00.00%
Solid Biosciences Inc.0US$00.00%
Upstream Bio, Inc.0US$00.00%
Vaxcyte, Inc.0US$00.00%
Vir Biotechnology, Inc.0US$00.00%
Zura Bio Limited0US$00.00%
Apogee Therapeutics, Inc.0US$00.00%
Avalo Therapeutics, Inc.0US$00.00%
Cogent Biosciences, Inc.0US$00.00%
Corvus Pharmaceuticals, Inc.0US$00.00%
Cybin, Inc.0US$00.00%
Sensei Biotherapeutics, Inc.0US$00.00%
Forte Biosciences, Inc.0US$00.00%
Inovio Pharmaceuticals, Inc.0US$00.00%
Invivyd, Inc.0US$00.00%
LB Pharmaceuticals Inc0US$00.00%
MapLight Therapeutics, Inc.0US$00.00%
Ocular Therapeutix, Inc.0US$00.00%
Odyssey Therapeutics, Inc.0US$00.00%
ORIC Pharmaceuticals, Inc.0US$00.00%
PepGen Inc.0US$00.00%
Praxis Precision Medicines, Inc.0US$00.00%
PTC Therapeutics, Inc.0US$00.00%

Source

Download original · View original at SEC

Related